Literature DB >> 25267900

Pharmacological interventions for obsessive-compulsive personality disorder.

Rajesh Alex1, Michael Ferriter1, Hannah Jones1, Nick Huband2, Conor Duggan2, Birgit A Völlm2, Jutta Stoffers3, Klaus Lieb4.   

Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows: To evaluate the potential beneficial and adverse effects of pharmacological interventions for people with obsessive-compulsive personality disorder and to make recommendations for future areas of research.

Entities:  

Year:  2010        PMID： 25267900      PMCID： PMC4176665          DOI： 10.1002/14651858.CD008517

Source DB:  PubMed          Journal:  Cochrane Database Syst Rev        ISSN： 1361-6137


  34 in total

1.  Treatment of features of Obsessive-Compulsive Personality Disorder using carbamazepine.

Authors:  Kevin W Greve; Donald Adams
Journal:  Psychiatry Clin Neurosci       Date:  2002-04       Impact factor: 5.188

2.  Statistical methods for the meta-analysis of cluster randomization trials.

Authors:  A Donner; G Piaggio; J Villar
Journal:  Stat Methods Med Res       Date:  2001-10       Impact factor: 3.021

3.  Algorithms for pharmacological treatment of personality dimensions: symptom-specific treatments for cognitive-perceptual, affective, and impulsive-behavioral dysregulation.

Authors:  P H Soloff
Journal:  Bull Menninger Clin       Date:  1998

4.  The Social Functioning Questionnaire: a rapid and robust measure of perceived functioning.

Authors:  Peter Tyrer; Ula Nur; Mike Crawford; Saffron Karlsen; Claire McLean; Bharti Rao; Tony Johnson
Journal:  Int J Soc Psychiatry       Date:  2005-09

5.  Standardised assessment and recording of depressive symptoms.

Authors:  M Hamilton
Journal:  Psychiatr Neurol Neurochir       Date:  1969 Mar-Apr

6.  The prevalence of DSM-IV personality disorders in psychiatric outpatients.

Authors:  Mark Zimmerman; Louis Rothschild; Iwona Chelminski
Journal:  Am J Psychiatry       Date:  2005-10       Impact factor: 18.112

7.  An open trial of valproate in borderline personality disorder.

Authors:  D J Stein; D Simeon; M Frenkel; M N Islam; E Hollander
Journal:  J Clin Psychiatry       Date:  1995-11       Impact factor: 4.384

8.  Cerebrospinal fluid vasopressin levels: correlates with aggression and serotonin function in personality-disordered subjects.

Authors:  E F Coccaro; R J Kavoussi; R L Hauger; T B Cooper; C F Ferris
Journal:  Arch Gen Psychiatry       Date:  1998-08

9.  Clomipramine in the treatment of patients with obsessive-compulsive disorder. The Clomipramine Collaborative Study Group.

Authors: 
Journal:  Arch Gen Psychiatry       Date:  1991-08

10.  Pharmacotherapy of borderline personality disorder. Alprazolam, carbamazepine, trifluoperazine, and tranylcypromine.

Authors:  R W Cowdry; D L Gardner
Journal:  Arch Gen Psychiatry       Date:  1988-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.